Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO) Human Receptor Crystallography Project, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. JST, Research Acceleration Program, Membrane Protein Crystallography Project, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Department of Cell Biology, Kyoto University Faculty of Medicine, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan.
Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO) Human Receptor Crystallography Project, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan. Department of Cell Biology, Kyoto University Faculty of Medicine, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan.
Science. 2015 Nov 6;350(6261):680-4. doi: 10.1126/science.aaa4335.
Anion exchanger 1 (AE1), also known as band 3 or SLC4A1, plays a key role in the removal of carbon dioxide from tissues by facilitating the exchange of chloride and bicarbonate across the plasma membrane of erythrocytes. An isoform of AE1 is also present in the kidney. Specific mutations in human AE1 cause several types of hereditary hemolytic anemias and/or distal renal tubular acidosis. Here we report the crystal structure of the band 3 anion exchanger domain (AE1(CTD)) at 3.5 angstroms. The structure is locked in an outward-facing open conformation by an inhibitor. Comparing this structure with a substrate-bound structure of the uracil transporter UraA in an inward-facing conformation allowed us to identify the anion-binding position in the AE1(CTD), and to propose a possible transport mechanism that could explain why selected mutations lead to disease.
阴离子交换蛋白 1(AE1),也称为带 3 或 SLC4A1,在通过促进红细胞质膜上的氯离子和碳酸氢根离子交换来从组织中去除二氧化碳方面发挥关键作用。AE1 的同工型也存在于肾脏中。人类 AE1 的特定突变导致几种遗传性溶血性贫血和/或远端肾小管性酸中毒。在这里,我们报告了 3.5 埃的带 3 阴离子交换蛋白结构域(AE1(CTD))的晶体结构。该结构被抑制剂锁定在向外打开的构象中。将该结构与向内打开构象的尿嘧啶转运蛋白 UraA 的底物结合结构进行比较,使我们能够确定 AE1(CTD)中的阴离子结合位置,并提出一种可能的运输机制,该机制可以解释为什么某些突变会导致疾病。